help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 4, 2009
Endocrinology, doi:10.1210/en.2009-0272
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
150/9/4395    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Wu, Y.
Right arrow Articles by LeRoith, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, Y.
Right arrow Articles by LeRoith, D.

Submitted on March 9, 2009
Accepted on May 22, 2009

Elevated levels of IGF-1 in serum rescue the severe growth retardation of IGF-1 null mice

YingJie Wu, Hui Sun, Shoshana Yakar*, and Derek LeRoith

Division of Endocrinology, Diabetes and Bone disease, Mount Sinai School of Medicine, New York, NY 10029

* To whom correspondence should be addressed. E-mail: shoshana.yakar{at}mssm.edu.

Insulin-like growth factor-1 (IGF-1) plays a vital role in growth and development, and acts in an endocrine and an autocrine/paracrine fashion. The purpose of the current study was to clarify whether elevated levels of IGF-1 in serum can rescue the severe growth retardation and organ development and function of igf-1 null mice. To address that, we overexpressed a rat igf-1 transgene specifically in the liver of igf-1 null mice. We found that in the total absence of tissue IGF-1, elevated levels of IGF-1 in serum can support normal body size at puberty and post-puberty, but are insufficient to fully support female reproductive system (evident by irregular estrous cycle, impaired development of ovarian corpus luteum, reduced number of uterine glands and endometrial hypoplasia, all leading to decreased number of pregnancies and litter size). We conclude that most autocrine/paracrine actions of IGF-1 that determine organ growth and function, can be compensated by elevated levels of endocrine IGF-1. However, in mice, full compensatory responses are evident later in development, suggesting that autocrine/paracrine IGF-1 is critical for neonatal development. Furthermore, we show that tissue IGF-1 is necessary for the development of female reproductive system and cannot be compensated by elevated levels of serum IGF-1.


Key words: IGF-1 • GH • growth • reproduction • fertility • transgenic • endocrine IGF-1







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society